Secondary Logo

Institutional members access full text with Ovid®

Ahmed Glaucoma Valve Revision Versus Visco-Trabeculotomy After Failed Ahmed Glaucoma Valve in Refractory Pediatric Glaucoma

Elwehidy, Ahmed S., MD, PhD*; Badawi, Amani E., MD, PhD*; Hagras, Sherein M., MD*; Bayoumi, Nader H.L., MD, FRCS (Glasgow)

doi: 10.1097/IJG.0000000000001149
Original Studies

Purpose: To compare the outcome of the intraocular pressure (IOP) of Ahmed glaucoma valve (AGV) revision to visco-trabeculotomy (VT) in children’s eyes with failed AGV.

Patients and Methods: A prospective randomized study conducted on 41 children (41 eyes) with uncontrolled glaucoma with an AGV presenting to the pediatric ophthalmology clinic of Mansoura Ophthalmic Center between 2011 and 2016. Study eyes were randomized to AGV revision or VT. Success (true and qualified) (IOP<21 mm Hg without any sight-threatening complications) was studied at the end of 12-month follow-up. Operative complications were noted. The primary outcome was the IOP before and after the study intervention.

Results: The mean±SD age of the study children was 7.9±2.6 and 7.7±2.6 years in the AGV revision (19 eyes) and VT groups (22 eyes), respectively (P=0.654). The most common glaucoma type was primary congenital glaucoma in both groups. The mean±SD of the duration between the last glaucoma procedure and the current study intervention was 24.9±4.8 and 25.2±5.8 months in the AGV revision and VT groups, respectively. The mean±SD preoperative IOP and at 12-month follow-up was 32.1±3.2 and 23.2±3.5 mm Hg in the AGV revision group and was 33.3±2.2 and 20.0±3.5 mm Hg in the VT group. The total success rates at 12 months were 31.6% and 63.7% in the AGV revision and VT groups, respectively.

Conclusions: Both VT and AGV revision are reasonably successful and safe interventions for refractory childhood glaucoma after the failure of an AGV. VT is significantly better than AGV revision, resulting in higher success rates and a decrease in IOP-lowering medication use.

*Department of Ophthalmology, Faculty of Medicine, Mansoura University, Mansoura

Department of Ophthalmology, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Disclosure: The authors declare no conflict of interest.

Reprints: Nader H.L. Bayoumi, MD, FRCS (Glasgow), Department of Ophthalmology, Faculty of Medicine, Alexandria University, 311, Horeya Avenue, Sporting, 10th Floor, App 1004, Alexandria 21311, Egypt (e-mail:

Received June 15, 2018

Accepted November 27, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.